Lev Pharmaceuticals

About:

Lev Pharmaceuticals is focused on developing therapeutic products for the treatment of inflammatory diseases.

Top Investors: Southpoint Capital Advisors, Mast Capital Management, Rosalind Capital Partners, Emigrant Capital, Alexandra Investment Management

Description:

Lev Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on developing and commercializing therapeutic products for the treatment of inflammatory diseases. Its products include C1-INH that is used for the treatment of hereditary angioedema. The company was founded in 2003 and is based in New York, New York. As of October 21, 2008, Lev Pharmaceuticals, Inc. operates as a subsidiary of ViroPharma Inc.